Gary Sender's Net Worth

$1.78 Million

Estimate Recalculated Jun 20, 2024 03:25PM EST

Who is Gary Sender?

Gary Sender has an estimated net worth of $1.78 Million. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Schrodinger, Inc., Harmony Biosciences Holdings, Inc., Nabriva Therapeutics plc, iBio, Inc., and Synergy Pharmaceuticals, Inc..

SEC CIK

Gary Sender's CIK is 0001659085

Past Insider Trading and Trends

2020 was Gary Sender's most active year for acquiring shares with 6 total transactions. Gary Sender's most active month to acquire stocks was the month of May. 2020 was Gary Sender's most active year for disposing of shares, totalling 14 transactions. Gary Sender's most active month to dispose stocks was the month of July. 2021 saw Gary Sender paying a total of $303,479.35 for 159,844 shares, this is the most they've acquired in one year. In 2021 Gary Sender cashed out on 57,618 shares for a total of $1,915,009.16, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nabriva Therapeutics Plc No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.2K
—
—
2.2K
Jun 23
No matching records found

Schrodinger, Inc. (SDGR) Snapshot price: $26.65

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+80.00%
5K
—
—
11.25K
Jun 18
Form 4
∞
6.25K
—
—
6.25K
Jun 15
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
$38.55
-$1,611,358.78
0
Mar 8
Form 4
—
0
—
—
0
Feb 10
Form 3
—
0
—
—
0
No matching records found

Harmony Biosciences Holdings, Inc. (HRMY) Snapshot price: $31.52

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
Aug 18
Form 3
—
0
—
—
0
No matching records found

Nabriva Therapeutics plc (NBRVF) Snapshot price: $0.0002

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.15%
-31.00
$2.39
-$74.09
20.47K
Feb 28
Form 4
-0.18%
-37.00
$2.62
-$96.94
20.5K
Jan 31
Form 4
-0.16%
-32.00
$2.42
-$77.44
20.54K
Dec 31
Form 4
-0.15%
-312.00
$0.43
-$133.22
205.73K
Nov 30
Form 4
-0.15%
-312.00
$0.50
-$154.60
206.04K
Oct 31
Form 4
-0.15%
-312.00
$0.53
-$166.30
206.35K
Sep 30
Form 4
-0.15%
-312.00
$0.62
-$193.25
206.66K
Aug 31
Form 4
+4.04%
8.05K
$0.65
-$2,074.91
206.98K
Aug 19 - Aug 20
Form 4
-0.16%
-312.00
$0.76
-$237.12
198.93K
Jul 31
Form 4
-0.16%
-312.00
$0.67
-$210.48
199.24K
Jun 30
Form 4
-0.16%
-312.00
$1.14
-$355.68
199.55K
May 31
Form 4
-0.16%
-301.00
$0.55
-$165.04
193.68K
Apr 30
Form 4
-0.15%
-301.00
$0.58
-$173.07
193.98K
Mar 31
Form 4
-0.15%
-301.00
$1.35
-$406.35
194.28K
Feb 28
Form 4
+133.47%
105K
—
—
183.67K
Feb 6
Form 4
-5.18%
-4.29K
$1.35
-$5,798.25
78.67K
Jan 31
Form 4/A
-15.00%
-3.39K
$2.08
-$7,051.20
19.21K
Aug 21
Form 4
+69.23%
7.86K
$2.08
-$7,051.20
19.21K
Aug 19 - Aug 21
Form 4
—
0
—
—
0
Jan 31
Form 4
+47.62%
2K
$4.57
$9,140.00
6.2K
May 23
Form 4
—
0
—
—
0
Jan 31
Form 4
+90.91%
2K
$8.21
$16,420.00
4.2K
Sep 22
Form 4
—
0
—
—
0
Feb 7
Form 3
—
0
—
—
0
No matching records found

iBio, Inc. (IBIO) Snapshot price: $1.09

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 9
Form 4
—
0
—
—
0
Oct 14
Form 3
—
0
—
—
0
No matching records found